Alfacalcidol Osteoporosis preventative. We need vitamin D to build strong bones and a lack of Vitamin D is one of the Causes of Osteopenia, Osteoporosis. Anyone with Osteopenia or Osteoporosis is likely to be advised to use a Vitamin D supplement.
But most Vitamin D supplements need 'activating' by your kidneys.
This can pose a difficulty for someone with kidney problems.
Alfacalcidol is a form of vitamin D which does not need this activation by your kidneys. That is why it may be prescribed for someone who has kidney issues.
Alfacalcidol will help your body absorb the calcium in your food and/or drink and so it can help strengthen your bones
If you have been prescribed the capsule form, be sure to store your Alfacalcidol Osteoporosis drug in a cool, dry place, away from direct heat and light.
If you have been prescribed drops, be sure to refrigerate them. Once your bottle has been opened, you should not use it for longer than 28 days. After 28 days you need to get a fresh supply.
1.Skin rash and itchiness
2. Loss of appetite, loss of weight
3. feeling sick
4. feeling thirsty
6. metallic taste in your mouth
7. need to pass urine more often
NOTE: Side effects 2 through 7 could be a sign that you have too much calcium in your blood. You should call and make an appointment with your health care provider immediately.
In September of 2014 a study was published in the Clinical Intervention Aging journal that compared the effect of Alfacalcidol with that of Menatetrenone, another form of Vitamin D , that was used among post menopausal Chinese women. The study showed no real advantage to either prescription form of Vitamin D. You can read the study at: Menatetrenone vs Alfacalcidol Osteoporosis study
An earlier study (2009) compared the effect of Alendronate vs Alfacalcidol on a group of Japanese men and the authors concluded that Aldendronate was more effective. The authors said"
"The present study confirmed that alendronate has better efficacy than
alfacalcidol (active control) in increasing hip BMD and reducing bone
turnover in Japanese men with osteoporosis" See: The present study confirmed that alendronate has better efficacy than alfacalcidol (active control) in increasing hip BMD and reducing bone turnover in Japa
or osteopenia with clinical risk factors for fractures.
See:Alendronate vs Alfacalcidol